Browse studies
Find your next paid study
15 recruiting studies matching your filters
Phase 1
A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
To evaluate safety and determine the recommended Phase II dose (RP2D). We hypothesize that targeting leukemia stem/progenitor cells (LSCs) with nadunolimab (IL…
Myelodysplastic Syndrome(MDS)Acute Myelogenous Leukemia (AML)
Estimated
~$10 – $6,250
M.D. Anderson Cancer CenterNCT06548230
The Prospective Collection, Storage and Reporting of Data on Patients
To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematop…
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more
Estimated
~$10 – $750
Wake Forest University Health SciencesNCT01890486
Phase 2
Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
The purpose of this study is to see if see if adding the specific combination of donors can result in acceptable levels of survival without evidence of disease.
aGVHDAcute Myelogenous LeukemiaAcute Lymphocytic Leukemia+1 more
Estimated
~$10 – $6,250
Case Comprehensive Cancer CenterNCT06904482